PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “SPOROTRICHOSIS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 397 records · Page 22Linked to original sources
PubMed1989

Epidemiology of sporotrichosis in Latin America.

Applying the concept of 'epidemiological chain', it is successively analyzed: the etiologic agent, Sporothrix schenckii and its natural reservoirs (sources of infection); the different ways that infecting particles may reach man (mechanisms of infection); the susceptible population and the population at risk; the incidence and distribution by sex and age in countries of Latin America; the prevalence of the disease according to clinical cases in dermatological clinics and the variation of incidence rates in some countries with time; the influence of the environment mainly climatic conditions on the geographic distribution of the disease. Finally, according to Mackinnon's hypothesis, the climate could have a determining role on the predominance of a certain clinical form on another in different countries.

Disease Susceptibility↗
PubMed1989

Feline sporotrichosis: a case report.

The isolation of Sporothrix schenckii from a female European cat it is described. The cat showed lengthened alopecic areas, with prominent nodules in the external surface of the thighs and abdomen. A mycological and histopathological studies of the lesions were carried out. The lesions resolved under treatment with 20% potassium iodide in doses of 0'1 ml/kg oral route in a 8 weeks period.

Animals↗
PubMed1984

Studies on sporotrichosis. Pathogenicity and morphogenesis in the Transvaal strains of Sporothrix schenckii.

In the Transvaal, two epidemiologic patterns of Sporothrix infection occur in man. Evidence gathered from nature, the clinic and the laboratory suggests that these patterns are not the result of either a fixed strain specificity or a random mutation. The differences represent a developmental trend, determined by environmental factors, which gradually transform the wild strains of Sporothrix schenckii into variants resembling the earlier descriptions of Sporothrix beurmannii. This change, moreover, is regular and predictable.

Aged↗
PubMed1986

Studies in sporotrichosis: fungal morphogenesis and pathogenicity in differing environments.

Sporothrix schenckii exhibits different morphology and pathogenic properties according to the source and circumstances of its growth. The present study considers the morphology and experimental pathogenicity in relation to - the 'wild' strains; the possible circumstances enhancing pathogenicity in strains recovered from the soil; the rate and nature of the transformational steps in morphology, in human and experimental infections by established pathogenic strains; the elimination of pathogenic strains to the surface of clinical lesions, enabling a simplified diagnostic proof of infection; the rate and nature of the reversion of pathogenic forms to the 'wild' type when the constraints of the host are lessened; the plasticity of conidium-pigmentation as a sign of pathogenicity; the morphological conversions on moist wattle-wood as occur in the Gold Mines; and a note on the therapeutic value of itraconazole. Host resistance is seen to play a larger part in morphology of the pathogenic phase, and exhaustion of natural food resources as the generator of potentially pathogenic forms.

Animals↗
PubMed1992

Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice.

Congenitally athymic nude (nu/nu) mice showed higher sensitivity to intratestical infection of Sporothrix schenckii than phenotypically normal littermates (nu/+). Active immunization with viable cells enhanced the resistance to intravenous (i.v.) infection of this fungus in BALB/c mice. Nu/nu mice transferred with immune spleen cells acquired the enhancement of resistance to the infection with S. schenckii, but not ones with normal spleen cells. Pre-treatment of OK-432 (Picibanil), one of the macrophage activating agents, enhanced resistance to i.v. infection of this fungus in BALB/c mice. On the other hand, pretreatment of carrageenan, one of the macrophage inhibitors, impaired the resistance. This fungus was intracellularly killed by peritoneal macrophage from OK-432 treated or immunized mice but not by those from normal mice in vitro. These results suggest that activated macrophage, that was mediated by T cells, play an important role in the resistance to S. schenckii in mice.

Animals↗
PubMed1994

Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis.

Production of Interleukin-1 (IL-1) and Tumor Necrosis Factor (TNF) by adherent peritoneal cells from BALB/c mice was measured at week 2, 4, 6, 8 and 10 after intravenous inoculation with 10(6) Sporothrix schenckii yeasts. As compared with age-matched controls, IL-1 and TNF production by adherent peritoneal cells from S. schenckii-infected mice was reduced severely at week 4 and 6 of infection and greater than normal at week 8 and 10. Moreover, between week 4 and 6 of infection there was a depression of delayed type hypersensitivity response to a specific whole soluble antigen, and an increase in fungal multiplication in the livers and spleens of infected mice. Thus, the deficits of cell-mediated immunity in mice with systemic S. schenckii infection may derive, in part, from impaired amplification of the immune response consequent to abnormal generation of IL-1 and TNF.

Animals↗